The Louisville Statement (2008) represented the first international consensus on laparoscopic liver surgery. Forty-five experts convened and concluded that laparoscopic liver resection was feasible and safe for solitary lesions ≤5 cm in anterolateral segments (2-6), while major hepatectomies were reserved for experienced surgeons. This consensus provided the framework for subsequent adoption but acknowledged the need for randomized evidence.

Louisville Statement2009Landmark

International consensus: laparoscopic liver resection acceptable for solitary lesions ≤5 cm in segments 2-6

Ann SurgConsensus0

Proof

Landmark RCTs and pivotal trials that established the evidence base

The Oslo-CoMet trial (2018) was the first RCT comparing laparoscopic and open parenchyma-sparing liver resection for colorectal liver metastases. Among 280 randomized patients, laparoscopic surgery reduced postoperative complications (19% vs 31%) with equivalent R0 resection rates and long-term survival (median OS 80 vs 81 months, p=0.91). The ORANGE II trial demonstrated noninferiority of laparoscopic left lateral sectionectomy within an ERAS program, further validating the minimally invasive approach for selected resections.

ORANGE II2017

Time to functional recovery — no significant difference between laparoscopic and open approaches

Br J SurgRCTN=57

Oslo-CoMet2018Landmark

Postoperative complications ≥grade 2 — laparoscopic 19% vs open 31% (p=0.021); median OS equivalent

Ann SurgRCTN=280

Extension

Follow-up studies, subgroup analyses, and real-world validation

The ORANGE II PLUS trial (2024), the largest RCT of laparoscopic versus open hemihepatectomy, randomized 332 patients and demonstrated significantly faster functional recovery with laparoscopic surgery (4 vs 5 days, p<0.001) with equivalent major complication rates. Time to adjuvant chemotherapy was also shorter in the laparoscopic group (46.5 vs 62.8 days, p=0.009). This trial extended the evidence base to major hepatectomy, previously considered the domain of open surgery.

ORANGE II PLUS2024Landmark

Time to functional recovery — laparoscopic 4 days vs open 5 days (difference -17.5%, p<0.001)

Journal of clinical oncology : official journal of the American Society of Clinical OncologyRCTN=332

Guidelines

Integration into clinical practice guidelines and recommendations

The Southampton Consensus (2018) updated the Louisville Statement, endorsing laparoscopic liver resection as standard practice for minor resections in anterolateral segments and as an acceptable alternative for major hepatectomies at experienced centers. The evidence base from Oslo-CoMet and ORANGE II PLUS strengthened these recommendations.

Southampton Consensus

Laparoscopic minor liver resection standard for anterolateral segments; major hepatectomy acceptable at experienced centers

Now

Current standard of care and ongoing research directions

Laparoscopic liver surgery has evolved from an experimental technique to an evidence-based standard for selected resections. The Oslo-CoMet, ORANGE II, and ORANGE II PLUS trials provide randomized evidence supporting both minor and major laparoscopic hepatectomy. Robotic liver surgery is gaining traction, particularly for complex posterosuperior segment resections. The frontier includes augmented reality navigation, ICG fluorescence guidance, and extending minimally invasive approaches to the most complex hepatic resections.

Landmark Trials in This Story

Louisville Statement2009Landmark

The international position on laparoscopic liver surgery: The Louisville Statement, 2008

International consensus: laparoscopic liver resection acceptable for solitary lesions ≤5 cm in segments 2-6

Ann SurgConsensus0

ORANGE II2017

Randomized clinical trial of open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery after surgery programme (ORANGE II study)

Time to functional recovery — no significant difference between laparoscopic and open approaches

Br J SurgRCTN=57

Oslo-CoMet2018Landmark

Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial

Postoperative complications ≥grade 2 — laparoscopic 19% vs open 31% (p=0.021); median OS equivalent

Ann SurgRCTN=280

ORANGE II PLUS2024Landmark

Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial

Time to functional recovery — laparoscopic 4 days vs open 5 days (difference -17.5%, p<0.001)

Journal of clinical oncology : official journal of the American Society of Clinical OncologyRCTN=332

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3M+ peer-reviewed articles.

Ask about Laparoscopic Liver Surgery Try AttendMe Free

Related Evidence

Colorectal Surgery

Laparoscopic vs Open Colorectal Cancer Surgery

Equivalent oncologic outcomes

Cardiothoracic Surgery

Minimally Invasive Cardiac Surgery

Through smaller windows

Frequently Asked Questions

Is laparoscopic liver surgery as safe as open surgery for cancer?+

The Oslo-CoMet trial (280 patients) demonstrated that laparoscopic parenchyma-sparing liver resection for colorectal metastases reduced complications (19% vs 31%) with equivalent R0 resection rates and median overall survival (80 vs 81 months). ORANGE II PLUS (332 patients) confirmed faster functional recovery after laparoscopic major hepatectomy (4 vs 5 days) with equivalent complication rates. These RCTs provide strong evidence for oncologic safety.

What types of liver resections can be done laparoscopically?+

The Louisville Statement (2008) initially recommended laparoscopy for solitary lesions ≤5 cm in anterolateral segments 2-6. With accumulating evidence and experience, the Southampton Consensus (2018) extended the indication to major hepatectomy at experienced centers. The ORANGE II PLUS trial (2024) specifically demonstrated safety and superiority of laparoscopic hemihepatectomy, confirming the feasibility of major laparoscopic liver resections.